P. Aeruginosa Metabolites May Enable Better Patient Management

Molecules produced by the environmental bacteria Pseudomonas aeruginosa, called alkyl-quinolones derivatives — which regulate bacterial gene activity and act in cell-to-cell communication — may be useful markers for better management of patients with cystic fibrosis (CF), a study suggests. These derivatives also may enable a more clear definition…

Bacteria May Increase Risk of Fungal Infection in Cystic Fibrosis Patients’ Lungs, Study Reports

Certain bacteria may increase the risk of fungal colonization in cystic fibrosis (CF) patients, according to a study in Germany. CF makes a patient susceptible to chronic airway inflammation and infections, resulting in lung tissue damage. Scientists have long known that bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus play roles…

Researchers Offer New Insights Into the Pulmonary Microbiota of Cystic Fibrosis Patients

A study recently published in the journal SpringerPlus revealed new insights into the pulmonary microbiota in patients with cystic fibrosis and the impact of Pseudomonas aeruginosa infection. The study is entitled “Insights into the respiratory tract microbiota of patients with cystic fibrosis during early…

Common Bacteria that Causes Pneumonia Found To Be Rare in CF Patients

Researchers at the University of Calgary in Canada have recently published in the journal BMC Pulmonary Medicine findings indicating that lung colonization by the bacteria Streptococcus pneumonia is relatively rare in patients with cystic fibrosis (CF) and when present, it apparently does not have an adverse impact…